This two-day, interactive meeting, will provide the opportunity to examine the latest research into microbial
communities with a focus on translation to therapeutics. Across two separate tracks, key topics such as pharmaceutical
involvement, venture capital investment, and R&D, both inside and outside the gut, will be covered.
In addition, there will be a vibrant exhibition room, 10 expert-led roundtable debates, 3 interactive panel discussions
and venture capital pitch and partner sessions, providing numerous opportunities to seek partnerships and funding.